Clinical Trials Logo

Abnormal Uterine and Vaginal Bleeding, Unspecified clinical trials

View clinical trials related to Abnormal Uterine and Vaginal Bleeding, Unspecified.

Filter by:
  • None
  • Page 1

NCT ID: NCT01612065 Completed - Infertility Clinical Trials

Optimum Misoprostol Dose Prior to Office Hysteroscopy

Start date: June 2012
Phase: Phase 3
Study type: Interventional

Misoprostol is an effective agent for cervical priming before office hysteroscopy, vaginal route is the best, optimum dose not yet known.